- Home
- ELWS vs XXII Comparison
ELWS vs XXII Comparison
Compare ELWS & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELWS
- XXII
- Stock Information
- Founded
- ELWS 2018
- XXII 1998
- Country
- ELWS Japan
- XXII United States
- Employees
- ELWS N/A
- XXII N/A
- Industry
- ELWS
- XXII Medicinal Chemicals and Botanical Products
- Sector
- ELWS
- XXII Health Care
- Exchange
- ELWS Nasdaq
- XXII Nasdaq
- Market Cap
- ELWS 6.1M
- XXII 7.0M
- IPO Year
- ELWS 2023
- XXII N/A
- Fundamental
- Price
- ELWS $1.83
- XXII $7.45
- Analyst Decision
- ELWS
- XXII
- Analyst Count
- ELWS 0
- XXII 0
- Target Price
- ELWS N/A
- XXII N/A
- AVG Volume (30 Days)
- ELWS 109.6K
- XXII 38.7K
- Earning Date
- ELWS 07-07-2025
- XXII 08-12-2025
- Dividend Yield
- ELWS N/A
- XXII N/A
- EPS Growth
- ELWS N/A
- XXII N/A
- EPS
- ELWS N/A
- XXII N/A
- Revenue
- ELWS $2,292,406.00
- XXII $23,869,000.00
- Revenue This Year
- ELWS N/A
- XXII $22.41
- Revenue Next Year
- ELWS N/A
- XXII $76.35
- P/E Ratio
- ELWS N/A
- XXII N/A
- Revenue Growth
- ELWS 404.13
- XXII N/A
- 52 Week Low
- ELWS $1.04
- XXII $6.28
- 52 Week High
- ELWS $8.68
- XXII $2,837.04
- Technical
- Relative Strength Index (RSI)
- ELWS 31.96
- XXII 21.75
- Support Level
- ELWS $1.85
- XXII $6.81
- Resistance Level
- ELWS $2.16
- XXII $9.50
- Average True Range (ATR)
- ELWS 0.10
- XXII 1.74
- MACD
- ELWS -0.03
- XXII -0.14
- Stochastic Oscillator
- ELWS 0.02
- XXII 11.38
About ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.